SEARCH RESULT

Total Matching Records found : 124

Fight Covid with compulsory licensing -Amitendu Palit

-Financial Express If patents continue to determine global access to vaccines and drugs, then fighting Covid-19 will remain a distant dream for most countries Vaccines are badly required by the world, as are drugs like Remdesivir and Tocilizumab, and medical equipment like ventilators and oxygen concentrators. A large number of countries, particularly low- and middle-income ones, are struggling to access vaccines, drugs and equipment. There cannot be a more important occasion than the...

More »

Vaccines bought first using PM CARES funds cost Centre more -Priscilla Jebaraj and Jacob Koshy

-The Hindu Current price negotiated through bulk orders may not be replicable: Finance Secy The first lot of vaccines were procured by the Centre using PM CARES funds at a higher rate than the subsequent rounds paid for by budgetary allocations, The Hindu has learnt from the response to a Right to Information request by a transparency activist. The Health Ministry response said that the initial 5.6 crore doses of Covishield were bought...

More »

India learns a bitter lesson for disregarding crucial warnings and recommendations on Covid-19

In the month of April this year, there has been an unprecedented upsurge in daily new cases and daily new deaths in the country due to Covid-19. States, which reported large increases in daily new cases and daily new deaths, are Maharashtra, Kerala, Karnataka, Delhi and Uttar Pradesh, to name but a few.   Data accessed from https://www.covid19india.org/, which is a crowdsourced platform and an independent aggregator of daily Covid-19 figures and...

More »

ADB sees India grow by 11%, adds caveat

-The Hindu Lender sees ‘considerable downside risk’ from latest COVID wave, says may revise forecast in July The Asian Development Bank has raised its forecast for India’s growth in 2021-22 to 11%, from 8% earlier, even as it warned that failure to control the resurgence of COVID-19 cases including April’s exponential jump poses a “considerable downside risk to the recovery”. ‘Targeted containment’ In its assessment based on end-March data, the ADB cited this year’s...

More »

How India landed in Covid vaccine mess - GS Mudur

-The Telegraph The Centre had last November announced a Rs 900-crore project but none of this money went to either Covishield or Covaxin India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close